Robichaux William G, Oner Sukru S, Lanier Stephen M, Blumer Joe B
Department of Cell and Molecular Pharmacology and Experimental Therapeutics (W.G.R., S.S.O., S.M.L., J.B.B.) and Department of Neurosciences (J.B.B.), Medical University of South Carolina, Charleston, South Carolina.
Department of Cell and Molecular Pharmacology and Experimental Therapeutics (W.G.R., S.S.O., S.M.L., J.B.B.) and Department of Neurosciences (J.B.B.), Medical University of South Carolina, Charleston, South Carolina
Mol Pharmacol. 2015 Aug;88(2):231-7. doi: 10.1124/mol.115.097741. Epub 2015 May 13.
Group II activator of G-protein signaling (AGS) proteins contain one or more G-protein regulatory motifs (GPR), which serve as docking sites for GαiGDP independent of Gβγ and stabilize the GDP-bound conformation of Gαi, acting as guanine nucleotide dissociation inhibitors. The GαGPR interaction is regulated by seven-transmembrane-spanning (7TM) receptors in the intact cell as determined by bioluminescence resonance energy transfer (BRET). It is hypothesized that a 7TM receptor directly couples to the GαGPR complex in a manner analogous to receptor coupling to the Gαβγ heterotrimer. As an initial approach to test this hypothesis, we used BRET to examine 7TM receptor-mediated regulation of GαGPR in the intact cell when Gαi2 yellow fluorescent protein (YFP) was tethered to the carboxyl terminus of the α2A adrenergic receptor (α2AAR-Gαi2YFP). AGS3- and AGS4-Renilla luciferase (Rluc) exhibited robust BRET with the tethered GαiYFP, and this interaction was regulated by receptor activation localizing the regulation to the receptor microenvironment. Agonist regulation of the receptor-Gαi-GPR complex was also confirmed by coimmunoprecipitation and cell fractionation. The tethered Gαi2 was rendered pertussis toxin-insensitive by a C352I mutation, and receptor coupling to endogenous Gαi/oβγ was subsequently eliminated by cell treatment with pertussis toxin (PT). Basal and agonist-induced regulation of α2AAR-Gαi2YFP(C352I):AGS3Rluc and α2AAR-Gαi2YFP(C352I):AGS4Rluc BRET was not altered by PT treatment or Gβγ antagonists. Thus, the localized regulation of GαGPR by receptor activation appears independent of endogenous Gαi/oβγ, suggesting that GαiAGS3 and GαiAGS4 directly sense agonist-induced conformational changes in the receptor, as is the case for 7TM receptor coupling to the Gαβγ heterotrimer. The direct coupling of a receptor to the GαiGPR complex provides an unexpected platform for signal propagation with broad implications.
G蛋白信号转导(AGS)蛋白的第二组激活剂包含一个或多个G蛋白调节基序(GPR),这些基序作为GαiGDP的停靠位点,独立于Gβγ,并稳定Gαi的GDP结合构象,起到鸟嘌呤核苷酸解离抑制剂的作用。通过生物发光共振能量转移(BRET)测定,在完整细胞中,GαGPR相互作用受七跨膜(7TM)受体调控。据推测,7TM受体以类似于受体与Gαβγ异源三聚体偶联的方式直接与GαGPR复合物偶联。作为检验这一假设的初步方法,当Gαi2黄色荧光蛋白(YFP)连接到α2A肾上腺素能受体(α2AAR-Gαi2YFP)的羧基末端时,我们使用BRET检测完整细胞中7TM受体介导的GαGPR调控。AGS3和AGS4海肾荧光素酶(Rluc)与连接的GαiYFP表现出强烈的BRET,并且这种相互作用受受体激活调控,将调控定位到受体微环境。受体-Gαi-GPR复合物的激动剂调控也通过共免疫沉淀和细胞分级分离得到证实。通过C352I突变使连接的Gαi2对百日咳毒素不敏感,随后用百日咳毒素(PT)处理细胞消除受体与内源性Gαi/oβγ的偶联。PT处理或Gβγ拮抗剂不会改变α2AAR-Gαi2YFP(C352I):AGS3Rluc和α2AAR-Gαi2YFP(C352I):AGS4Rluc BRET的基础和激动剂诱导调控。因此,受体激活对GαGPR的局部调控似乎独立于内源性Gαi/oβγ,这表明GαiAGS3和GαiAGS4直接感知激动剂诱导的受体构象变化,就像7TM受体与Gαβγ异源三聚体偶联的情况一样。受体与GαiGPR复合物的直接偶联为信号传播提供了一个意想不到的平台,具有广泛的意义。